NCT00004220View on ClinicalTrials.gov

Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 1999

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

gemcitabine hydrochloride

DRUG

oxaliplatin

Trial Locations (3)

95817

University of California Davis Cancer Center, Sacramento

91010-3000

Cancer Center and Beckman Research Institute, City of Hope, Duarte

90033-0804

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT00004220 - Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter